Latest News and Updates

Contract Research Organization Nanjing YZ Clinical Trials & Consulting Co., Ltd.  within an international group of companies ZM CRO GROUP www.zmcro.cn, with long-term (more than 20 years) experience of successful cooperation with the pharmaceutical companies within the multinational projects for the safety provision of MP invites to......

Key words: Patient information leaflet (PIL), adverse reaction (AR), adverse event (AE), company core safety information (CCSI), summary of product characteristics (SmPC), unsolicited (spontaneous) reports (UR), solicited reports (SR), clinical trials (CT). Pharmacovigilance is a complex system that allows all parties involved in drug circulation to ensure medicinal......

Dear Сolleagues! It is our great pleasure to invite you to the webinar “5 KEY CHALLENGES OF PHARMACOVIGILANCE IN CHINA” presenting changes in pharmacovigilance practice after China joined ICH. Date: TBD Time: 2:00 PM (CET) Cost of Webinar: FREE Webinar language: in Chinese Webinar organizer: NJ......

NJ YZ  is participating in the China’s Top Domestic & Multinational Clinical Development Leaders Summit in Shanghai from 8th Nov. to 10th Nov. 2017. We will present more information later about this big event in China! For the event website, please check :http://www.chinatrialsevent.com/...

The real-world study conference was held from 29th June to 30th June in Shanghai 2017. In this meeting, Dr.Yuri Zaretsky presented a speech named RWE PHARMACOVIGILANCE: GLOBAL AND LOCAL OUTLOOK. In this speech, Dr. Yuri showed his ideas about PV in real word from global......

ZM CRO GROUP company President Dr. Yuri Zaretsky has recently started collaborating with Korea Health Industry Development Institute (KHIDI) as an official consultant for Korean pharmaceutical and biotechnology companies – Global Pharma Key Opinion Leader (GPKOL). As GPKOL Dr. Zaretsky is focused on the following......

Biological products (BP), or biologics, is a class of heterogeneous medical products derived from different natural source materials (mammalian, insect and plant cell cultures, yeast, etc.) intended to treat, cure, prevent or diagnose diseases and medical conditions [1, 5]. BP introduction to pharmaceutical market has......

November, 8-10 2016 managing director of ZM CRO GROUP Yuri Zaretsky will moderate series of sections and conduct a workshop for participants of annual Clinical Trials in Russia Forum (Russia, Moscow) organized by «Adam Smith Conferences» company. The sections will focus on data management and early access......

NJ YZ Clinical Trials and Consulting team is attending a networking event “China Bio Partnering Forum” held in Suzhou, China on May 18- 19, 2016....

NJ YZ Clinical Trials and Consulting in collaboration with Nanjing Biopharmaceutical Valley were pleased to present the first round of seminar series dedicated to the field of Clinical Trials. This introductory seminar provided the professionals in pharmaceutical and biotechnological communities with information on updates in......

ZM Company 3M Veritas Nanjing YZ Clinical Trial & Consulting